Top news of the week: 01.09.2020.
Medicine, Biotechnology, Pharmaceutical drug, Pharmacology, Infectious disease, Health care
Startups
RT @MassBio: In June, MassBio released its State of Possible 2025 report. To learn how this report will serve as a roadmap for the #LifeSciences for the next 5 years & beyond, we sat down with MassBio’s new Board Chair, & CEO & President of @UnumRx, Chuck Wilson. https://t.co/AFUDa05thu
OpenSustaining the Legacy of the Massachusetts Life Sciences Cluster
To learn more about how this report will serve as a roadmap for the next five years and beyond, we sat down with MassBio’s new Board Chair, and CEO & President of Unum Therapeutics, Chuck ...
Billionaire Patrick Soon-Shiong’s radical cancer treatments made him one of the wealthiest physicians on Earth. Now the master of medical marketing believes his drug therapies could defeat “the crisis of our time.”
Billionaire Patrick Soon-Shiong’s radical cancer treatments made him one of the wealthiest physicians on Earth. Now the master of medical marketing believes his drug therapies could defeat ...
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More
Among the casualties of the COVID-19 pandemic: the credibility of government agencies entrusted with protecting public health. The FDA this week granted
Working with the first tranche of a grant of up to £2.3 million ($3.0 million), Vaccitech plans to wrap up preclinical development of its asset and make enough doses to run a phase 1 trial that is expected to start next year. https://t.co/23SickwGsE
OpenBiotech behind AstraZeneca's COVID-19 vaccine advances next-gen prospect
Vaccitech has received U.K. government funding for a COVID-19 vaccine that it thinks can improve on first-generation prospects such as the AstraZeneca jab it helped develop.
Athira, armed with data on 11 patients, plans $100M IPO to fund pivotal Alzheimer's trial https://t.co/HLsjMrTvFy https://t.co/xynmTzloK0
OpenAthira, armed with data on 11 patients, plans $100M IPO to fund pivotal Alzheimer's trial
Athira Pharma has filed to raise $100 million on public markets to take a treatment for Alzheimer’s and Parkinson’s diseases through phase 2 clinical trials. The IPO will fund development ...
"Our nation's total investment is not tracking with disease burden. Increased investment in medical and health R&D is essential to ending diseases that are taking time and quality of life from Americans and people across the globe.” https://t.co/fCeyAwAGWe
OpenThe top 10 global R&D institutes
Many new drugs and diagnostics would never have seen the light of day if it wasn’t for academic and R&D institutes. Our top 10 are the most prolific when it comes to collabs and research ...
Chutes & Ladders—Apic brings on Solid Bio vet Quiroz to chief medical role https://t.co/3pnTm60NFm https://t.co/ujEYczvavL
OpenChutes & Ladders—Apic brings on Solid Bio vet Quiroz to chief medical role
Apic brings Quiroz over from Solid Bio as CMO; Kura nabs Dale as CMO; troubled Moffitt Cancer Centers brings on Hwu.
The startups will receive up to $500,000 in support, as well as mentorship from BARDA and J&J to help them navigate R&D challenge https://t.co/lr2c2UKtk2
OpenJ&J, BARDA pick 7 startups to back in fight against COVID-19—and beyond
As the world scrambles to develop diagnostics, treatments and vaccines for COVID-19, one big question looms: How will we face the next pandemic? Johnson & Johnson and the U.S. Biomedical ...